Lung Cancer

NON SMALL CELL

STAGE III

  • RTOG 0839 - Randomized Phase II Study of Pre-Operative Chemoradiotherapy +/- Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIA, N2+) NSCLC

STAGE IIIB/IV

  • SWOG S0819- A Randomized Phase III Trial of Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
  • ECOG E1512- A Randomized Phase II Trial of Erlotinib, Cabozantinib, or Erlotinib plus Cabozantinib as 2nd or 3rd Line Therapy in Patients with EGFR Wild-Type NSCLC (Temporary Closure)

SMALL CELL LUNG

  • RTOG 0937 - Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer (ES-SCLS)
  • ECOG E2511- Phase I and Randomized Phase II Double Blind Clinical Trial of Cisplatin and Etoposide in Combination with Veliparib (ABT-888) or Placebo as Frontline Therapy for Extensive Small Cell Lung Cancer

Metastatic Lung Cancer

  •  RTOG 0631- A Randomized Phase II/III Study of Image Guided Radiosurgery/SBRT for Localized Spine Metastasis

Mesothelioma

  • SWOG S0905- Randomized Phase II Study of Cediranib (NSC #732208) Versus Placebo in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Malignant Pleural Mesothelioma